Contraception
📧 Sign up to get email alerts when something new happens for Contraception.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: A Pilot Study of Early Expulsion Rates of the IUB™ SCu380A [NA]
Pilot study update on early expulsion rates of the IUB SCu380A in contraception; completed with results posted.
-
FDA approval · 2015-11-12FDA Approved: TRI FEMYNOR — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original application for TRI FEMYNOR (norgestimate and ethinyl estradiol) manufactured by Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: A Study to Evaluate the Safety and Initial Efficacy of a Novel Intrauterine Device [NA]
A completed clinical trial evaluating the safety and initial efficacy of a novel intrauterine device for contraception; results posted in 20…
-
FDA approval · 2015-10-28FDA Approved: BLISOVI 24 FE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved BLISOVI 24 FE as an original application for a generic combination oral contraceptive containing norethindrone acetate and ethi…
-
FDA approval · 2015-10-22FDA Approved: MIRENA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for MIRENA (levonorgestrel-releasing intrauterine system) from Bayer HealthCare Pharmaceuticals …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-08-21FDA Approved: NATAZIA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for NATAZIA, a combined oral contraceptive containing estradiol valerate and estradiol valerate/…
-
FDA approval · 2015-08-17FDA Approved: DROSPIRENONE AND ETHINYL ESTRADIOL — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's generic oral contraceptive product containing drospirenone and ethinyl estradiol under an Original Application (…
-
FDA approval · 2015-08-12FDA Approved: ISIBLOOM — Original Application (Xiromed, LLC.)
FDA approved ISIBLOOM, a generic oral contraceptive containing desogestrel and ethinyl estradiol, via an Original Application (ANDA) by Xiro…
-
FDA approval · 2015-07-22FDA Approved: TAYTULLA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for TAYTULLA, a combination oral contraceptive, submitted by Allergan, Inc.
-
FDA approval · 2015-06-17FDA Approved: LOJAIMIESS — Original Application (Xiromed LLC)
FDA approved LOJAIMIESS from Xiromed LLC as an original application for a combined levonorgestrel and ethinyl estradiol contraceptive tablet…
-
FDA approval · 2015-06-12FDA Approved: LEVONORGESTREL AND ETHINYL ESTRADIOL — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's levonorgestrel and ethinyl estradiol combination via an Original Application, establishing a new approved oral c…
-
FDA approval · 2015-05-21FDA Approved: VIENVA — Original Application (Xiromed, LLC.)
The FDA approved VIENVA (levonorgestrel and ethinyl estradiol) under the Original Application for ANDA 201088. Xiromed, LLC is the manufactu…
-
CLINICAL_TRIALS research · 2015-05-19Clinical Trial Update: Integrating Family Planning With Immunization to Improve Maternal and Child Health [NA]
Clinical trial update from Greenstar Social Marketing about integrating family planning with immunization to improve maternal and child heal…
-
FDA approval · 2015-05-16FDA Approved: ALYACEN 7/7/7 — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's supplemental application for ALYACEN 7/7/7, a generic norethindrone/ethinyl estradiol oral contraceptive.
-
FDA approval · 2015-05-16FDA Approved: ALYACEN 1/35 — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for ALYACEN 1/35, a generic combination product of norethindrone and ethinyl estradiol for contracep…
-
FDA approval · 2015-04-21FDA Approved: INTROVALE — Original Application (Xiromed LLC)
The FDA approved INTROVALE from Xiromed LLC as an original application for a generic levonorgestrel and ethinyl estradiol tablet for contrac…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Study of Self or Clinic Administration of DepoProvera [NA]
A completed clinical trial evaluating self- or clinic-administered Depo-Provera for contraception with results posted in 2015.
-
FDA approval · 2015-04-01FDA Approved: NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an abbreviated new drug application for norethindrone and ethinyl estradiol and ferrous fumarate as a generic oral contraceptiv…
-
FDA approval · 2015-02-23FDA Approved: ASHLYNA — Original Application (Glenmark Pharmaceuticals Inc., USA)
ASHLYNA is a generic oral contraceptive approved by the FDA under an original application (ANDA 203163) containing levonorgestrel and ethiny…
-
FDA approval · 2015-01-07FDA Approved: JINTELI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for JINTELI, providing approval related to its norethindrone acetate and ethinyl estradiol formu…
-
FDA approval · 2014-12-19FDA Approved: MONO-LINYAH — Supplemental Application (Northstar Rx LLC)
FDA approved the supplemental application for MONO-LINYAH (norgestimate and ethinyl estradiol) by Northstar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects [Phase 3]
Phase 3 results summarize the efficacy and safety of a combined oral contraceptive containing estradiol valerate and dienogest in healthy fe…
-
CLINICAL_TRIALS research · 2014-12-04Clinical Trial Update: NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel [Phase 1]
Phase 1 study NES Gel-1 evaluated Nestorone Gel in combination with Testosterone Gel for contraception and has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC)
Clinical trial update for an international active surveillance study evaluating oral contraceptives; status is completed with results posted…
-
FDA approval · 2014-09-30FDA Approved: YASMIN — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for YASMIN (drospirenone and ethinyl estradiol) submitted by Bayer HealthCare Pharmaceuticals.